methyl((1-methyl-1H-indol-2-yl)methyl)amine → (E)-(7-{2-[Methyl-(1-methyl-1H-indol-2-ylmethyl)carbamoyl]vinyl}-2-oxo-1,2,3,5-tetrahydro-pyrido[2,3-e][1,4]diazepin-4-yl)acetic acid ethyl ester hydrochloride

HRID 1711865Notes

Reaction equation

HRID 1711865 reaction equation
[CH3:1][NH:2][CH2:3][C:4]1[N:5]([CH3:13])[C:6]2[C:11]([CH:12]=1)=[CH:10][CH:9]=[CH:8][CH:7]=2.CNCC1C=CC2C(=CC=CC=2)C=1CCC.[ClH:30].[CH2:31]([O:33][C:34]([CH2:36][N:37]1[CH2:43][C:42]2[CH:44]=[C:45](/[CH:48]=[CH:49]/[C:50]([OH:52])=O)[CH:46]=[N:47][C:41]=2[NH:40][C:39](=[O:53])[CH2:38]1)=[O:35])[CH3:32].Cl.CN1CC2C=C(/C=C/C(O)=O)C=NC=2NC(=O)C1>>[ClH:30].[CH2:31]([O:33][C:34](=[O:35])[CH2:36][N:37]1[CH2:43][C:42]2[CH:44]=[C:45](/[CH:48]=[CH:49]/[C:50](=[O:52])[N:2]([CH3:1])[CH2:3][C:4]3[N:5]([CH3:13])[C:6]4[C:11]([CH:12]=3)=[CH:10][CH:9]=[CH:8][CH:7]=4)[CH:46]=[N:47][C:41]=2[NH:40][C:39](=[O:53])[CH2:38]1)[CH3:32]

Participants

5

Procedure

According to the procedure of Example 1, except substituting methyl-(1-methyl-1H-indol-2-ylmethyl)amine for the methyl-(1-propyl-naphthalen-2-ylmethyl)amine, and substituting (E)-3-(4-ethoxycarbonylmethyl-2-oxo-2,3,4,5-tetrahydro-1H-pyrido[2,3-e][1,4]diazepin-7-yl)acrylic acid hydrochloride for the (E)-3-(4-methyl-2-oxo-2,3,4,5-tetrahydro-1H-pyrido[2,3-e][1,4]diazepin-7-yl)acrylic acid hydrochloride, the title compound (0.22 g, 56%) was prepared as a yellow powder and as a mixture of amide rotamers: 1H NMR (300 MHz, DMSO-d6) δ 10.53-10.54 (m, 1H), 8.56-8.59 (m, 1H), 8.09-8.16 (m, 1H), 7.28-7.61 (m, 4H), 7.10-7.15 (m, 1H), 6.99-7.04 (m, 1H), 6.19-6.42 (m, 1H), 4.86-5.06 (m, 2H), 4.00-4.14 (m, 5H), 3.62-3.72 (m, 7H), 2.99-3.12 (m, 3H), 1.12-1.20 (m, 3H); MS (ESI) m/e 476 (M+H)+.

Sources & evidence

ORD record
ord-d6ea314a817c41b89112e89f9acd6f28
Source dataset
uspto-grants-2010_09
Patent number
US07790709B2

Reaction notes

Loading…